Press releases
Press releases
Here we list English translations of the Swedish press releases published by Neola Medical AB (publ). For official press releases, please visit our Swedish website.
Neola Medical Q4 report 2022 – Important milestone achieved when receiving certification according to ISO 13485
This is a translation of the Swedish press release published 2023-02-14, 08.00 CET Neola Medical AB (publ) today publishes the Q4 report of 2022 (in Swedish). The report is available at the company's website and is attached to the press release. A rights issue was...
Neola Medical invites to presentation of the Q4-report 2022
This is a translation of the Swedish press release published 2023-02-06 Neola Medical AB (publ) invites to presentation of the Q4-report of 2022, Tuesday the 14th of February 2023 at 11 am (CET, 11.00). The presentation will be held online as a video conference....
Market preparation work initiated before the launch of Neola Medical’s product
This is a translation of the Swedish press release published 2023-02-01 Neola Medical AB (publ) initiates market preparations before the launch of its medical device, Neola™ for continuous monitoring of the lungs of preterm born babies. The first action is a...
Neola Medicals trademark has been registered in China
This is a translation of the Swedish press release published 2023-01-24 Neola Medical AB (publ) announces today that the company’s trademark, Neola®, has been registered in China for class 10 (Medical device) and class 42 (Science and technology services, R&D...
Neola Medical and CEO Hanna Sjöström will participate at J.P. Morgan Healthcare Conference 2023 in San Francisco and present at Digital Medicine and Medtech Showcase
This is a translation of the Swedish press release published 2023-01-02 Neola Medical AB (publ) will attend the events related to investor conference J.P. Morgan Healthcare Conference in San Francisco in January 2023. CEO Hanna Sjöström will also present the...
Nomination committee in Neola Medical AB (publ) elected
This is a translation of the Swedish press release published 2022-12-20 The chairman of the board in Neola Medical AB (publ) have assembled a nomination committee. The nomination committee will develop proposals for the 2023 annual general meeting regarding the...
Neola Medical’s CEO tells more about the company’s latest news and milestones in new Investor Letter
This is a translation of the Swedish press release published 2022-12-15 Scientific article in leading international journal Pediatric Resarch, clinical study on 100 babies, preferential rights issue with new large shareholder, and important milestone achieved as of...
Neola Medical’s CEO Hanna Sjöström presents at ABGSC’s Investor Day the 6th of December
This is a translation of the Swedish press release published 2022-12-01 Neola Medical AB (publ) will participate at ABG Sundal Collier’s Investor Day in Stockholm the 6th of December and present the company. CEO Hanna Sjöström will present the company at 14.15...
Milestone achieved by Neola Medical – approved certification of quality management system according to ISO 13485
This is a translation of the Swedish press release published 2022-11-21 Neola Medical AB (publ) today announces that the company has received certification of the quality management system according to ISO 13485, which is a critical step towards achieving CE...
Neola Medical Q3 report 2022 – Important milestone reached as clinical study on 100 newborn babies was finalized
This is a translation of the Swedish press release published 2022-11-10, 08.15 CET Neola Medical AB (publ) today publishes the Q3 report of 2022 (in Swedish). The report is available at the company's website and is attached to the press release. The large clinical...
